Citation Impact
Citing Papers
Physical Activity and Public Health
2007 Standout
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Size regulation of von Willebrand factor–mediated platelet thrombi by ADAMTS13 in flowing blood
2005
The propeptide of von Willebrand Factor independently mediates the assembly of von Willebrand multimers
1988
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
1992 StandoutNature
Release of Biological Activities from Quiescent Fibronectin by a Conformational Change and Limited Proteolysis by Matrix Metalloproteinases
1995
Lipid rafts and signal transduction
2000 Standout
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Calbindin D-28k and parvalbumin in the rat nervous system
1990 Standout
The molecular basis of blood coagulation
1988 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Design and Synthesis of a Homogeneous Erythropoietin Analogue with Two Human Complex‐Type Sialyloligosaccharides: Combined Use of Chemical and Bacterial Protein Expression Methods
2009 StandoutNobel
Leisure Activities and the Risk of Dementia in the Elderly
2003 Standout
An ionizable lipid toolbox for RNA delivery
2021 StandoutNobel
Driving fast-spiking cells induces gamma rhythm and controls sensory responses
2009 StandoutNature
Mutation in blood coagulation factor V associated with resistance to activated protein C
1994 StandoutNature
The microenvironment of the tumour–host interface
2001 StandoutNature
Engineering Factor Viii for Hemophilia Gene Therapy
2012
Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins
1991 Standout
Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast-derived tissue plasminogen activator
1989
Characterization of the G Protein-coupled Receptor Kinase GRK4
1996 StandoutNobel
Inositol 1,4,5-Trisphosphate receptor causes formation of ER cisternal stacks in transfected fibroblasts and in cerebellar purkinje cells
1994 StandoutNobel
The function and differential sorting of a family of aplysia prohormone processing enzymes
1994 StandoutNobel
Interactions of human von Willebrand Factor with a hydrophobic self‐assembled monolayer studied by atomic force microscopy
1994
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Next Generation Sequencing Analysis of Human Platelet PolyA+ mRNAs and rRNA-Depleted Total RNA
2013 StandoutNobel
Disseminated Intravascular Coagulation
1999 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.
1989
Phosphatidylinositol 4,5-Bisphosphate (PIP2)-enhanced G Protein-coupled Receptor Kinase (GRK) Activity: LOCATION, STRUCTURE, AND REGULATION OF THE PIP2 BINDING SITE DISTINGUISHES THE GRK SUBFAMILIES
1996 StandoutNobel
The role of carbohydrate in recombinant human erythropoietin
1990
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Plasma .BETA.-Thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation.
1986
Formation and Structure of Self-Assembled Monolayers
1996 Standout
PC12 adhesion and neurite formation on selected substrates are inhibited by some glycosaminoglycans and a fibronectin-derived tetrapeptide
1986
Supramolecular Polymerization
2009 Standout
Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.
1990
Genomic organization of IgH gene compared with the expression of Bcl-2 gene in t(14;18)-positive lymphoma
1991 StandoutNobel
Lipid composition of lymphocyte plasma membrane from pig mesenteric lymph node
1976
Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.
1986
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.
1989 StandoutNobel
Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma.
1988
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology
1989 StandoutNature
Cytoskeletal Protein ABP-280 Directs the Intracellular Trafficking of Furin and Modulates Proprotein Processing in the Endocytic Pathway
1997 StandoutNobel
A Coagulation Factor IX-Deficient Mouse Model for Human Hemophilia B
1997 StandoutNobel
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
Structure of pre-pro-von Willebrand factor and its expression in heterologous cells
1986 Nature
Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase.
1994 StandoutNobel
ACSM Position Stand: Exercise and Physical Activity for Older Adults
1998 Standout
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
1993 Standout
Membrane-bound enzymes and membrane ultrastructure
1973
Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA sequence
1987
Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene
1990
The Hypercoagulable States
1985
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site.
1990
Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins.
1991
The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade.
1993
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Characterization of an interaction between protein C and ceruloplasmin.
1990
Gene deletions correlate with the development of alloantibodies in von Willebrand disease.
1987
Identification of the binding site for activated protein C on the light chain of factors V and VIII.
1990
ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults
1998 Standout
Proteolytic cleavage of the precursor of von Willebrand factor is not essential for multimer formation.
1988
Biologic and clinical significance of cryoglobulins
1974 Standout
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
1991
Isolation and functional expression of a mammalian prohormone processing enzyme, murine prohormone convertase 1.
1991 StandoutNobel
Antagonism of Catecholamine Receptor Signaling by Expression of Cytoplasmic Domains of the Receptors
1993 StandoutScienceNobel
Prohormone processing in Xenopus oocytes: characterization of cleavage signals and cleavage enzymes.
1991 StandoutNobel
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
2020
The influence of polyvalency on the binding properties of antibodies
1972
Nucleotide sequence of pre-pro-von Willebrand factor cDNA
1986
Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes.
1976 StandoutNobel
Biosynthesis of major platelet proteins in human blood platelets
1987
Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formation.
1987
Quantitative analysis of neurons and glial cells in the rat somatosensory cortex, with special reference to GABAergic neurons and parvalbumin-containing neurons
1992
An alternative approach to somatic cell gene therapy.
1988
Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule
1986
Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V
1984
Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor.
1994 StandoutNobel
C4b-binding protein exacerbates the host response to Escherichia coli
1991
Works of Stephen I. Chavin being referenced
Preventive Medicine and Screening in Older Adults
1997
Isolation and study of functional membrane proteins Present status and future prospects
1971
The size of human factor VIII heterodimers and the effects produced by thrombin
1986
Tyrosine optical activity as a probe of the conformation and interactions of fibronectin
1983
Biosynthesis of von Willebrand protein by human megakaryocytes.
1985
The effect of carbohydrate depletion on procoagulant activity and in vivo survival of highly purified human factor VIII
1984
Studies on Antigen-binding Activity of Macroglobulin Antibody Subunits and Their Enzymatic Fragments
1969
Factor VIII: Structure and function in blood clotting
1984
Inactivation of factor VIII by activated protein C and protein S
1987
PLASMA-THROMBOGLOBULIN CONCENTRATIONS IN DIABETES MELLITUS
1978
Propolypeptide of von Willebrand Factor Circulates in Blood and Is Identical to von Willebrand Antigen II
1986 Science
Plasma-membrane-associated immunoglobulins and other polypeptides of pig mesenteric node lymphocytes
1975
Purification and characterization of a highly purified human factor VIII consisting of a single type of polypeptide chain.
1982
Blood clotting factor IX. Loss of activity after cleavage of sialic acid residues.
1984